| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 1,580,000 | 90,249,000 | 19.89% | ||
| 2 | ARIAD PHARMACEUTICALS INC | 12,850,000 | 82,111,000 | 18.09% | ||
| 3 | BIOGEN INC | 310,000 | 80,699,000 | 17.78% | ||
| 4 | MEDICINES CO | 1,752,000 | 55,661,000 | 12.26% | ||
| 5 | QUEST DIAGNOSTICS INC | 575,000 | 41,083,000 | 9.05% | ||
| 6 | PACIRA BIOSCIENCES INC | 532,200 | 28,195,000 | 6.21% | ||
| 7 | INTRA CELLULAR THERAPIES INC COM | 675,000 | 18,764,000 | 4.13% | ||
| 8 | RAPTOR PHARMACEUTICAL CORP | 2,725,000 | 12,535,000 | 2.76% | ||
| 9 | Esperion Therapeutics Inc | 633,000 | 10,704,000 | 2.36% | ||
| 10 | AEGERION PHARMACEUTICALS INC | 2,580,000 | 9,546,000 | 2.10% | ||
| 11 | ARRAY BIOPHARMA INC COM | 2,875,000 | 8,481,000 | 1.87% | ||
| 12 | Apricus Biosciences, Inc. | 14,479,052 | 8,412,000 | 1.85% | ||
| 13 | VIVUS INC | 2,573,943 | 3,603,000 | 0.79% | ||
| 14 | AVEO PHARMACEUTICALS INC | 2,313,759 | 2,128,000 | 0.47% | ||
| 15 | REPROS THERAPEUTICS INC | 1,001,000 | 970,000 | 0.21% | ||
| 16 | TARGACEPT INC | 680,399 | 680,000 | 0.15% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-065701, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
